Cargando…
Breviscapine remodels myocardial glucose and lipid metabolism by regulating serotonin to alleviate doxorubicin-induced cardiotoxicity
Aims: The broad-spectrum anticancer drug doxorubicin (Dox) is associated with a high incidence of cardiotoxicity, which severely affects the clinical application of the drug and patients’ quality of life. Here, we assess how Dox modulates myocardial energy and contractile function and this could aid...
Autores principales: | Li, Meng-Jiao, Sun, Wen-She, Yuan, Yang, Zhang, Yu-Kun, Lu, Qi, Gao, Yuan-Zhen, Ye, Ting, Xing, Dong-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551275/ https://www.ncbi.nlm.nih.gov/pubmed/36238546 http://dx.doi.org/10.3389/fphar.2022.930835 |
Ejemplares similares
-
Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity
por: Qin, Yeyu, et al.
Publicado: (2022) -
Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review
por: Gao, Jialiang, et al.
Publicado: (2017) -
Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy
por: Zhou, Ji-Chao, et al.
Publicado: (2023) -
Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023) -
Bilirubin Improves Gap Junction to Alleviate Doxorubicin-Induced Cardiotoxicity by Regulating AMPK-Axl-SOCS3-Cx43 Axis
por: Zhang, Siqi, et al.
Publicado: (2022)